Nonblanching Rash on the Legs and Chest.

Cutis

Department of Dermatology, University of Michigan, Ann Arbor. Dr. Roszell also is from the Medical School, and Dr. Patel also is from the Department of Pathology, Sections of Dermatopathology and Bone and Soft Tissue Pathology.

Published: October 2022

Download full-text PDF

Source
http://dx.doi.org/10.12788/cutis.0639DOI Listing

Publication Analysis

Top Keywords

nonblanching rash
4
rash legs
4
legs chest
4
nonblanching
1
legs
1
chest
1

Similar Publications

Acute Haemorrhagic Oedema of Infancy (AHOI), also known as Acute Hemorrhagic Edema of Infancy (AHEI), is characterized by purpuric skin lesions, edema, and fever. It is classified as a form of cutaneous leukocytoclastic vasculitis. Clinically, AHOI presents with targetoid, purplish spots on the face and limbs, accompanied by the sudden onset of peripheral edema.

View Article and Find Full Text PDF
Article Synopsis
  • * This case report details an 18-year-old female patient whose SLE first presented with generalized muscle weakness, joint pain, and distinctive rashes indicative of lupus and vasculitis.
  • * After extensive testing, she was diagnosed and treated with a combination of medications, leading to significant improvement in her symptoms and muscle strength over time.
View Article and Find Full Text PDF

Background: There is a need to empower parents and carers of young infants to recognise signs of serious illness and to act on these appropriately. Compiling the signs and symptoms of serious illness in infants found in clinical guidelines will support the evidence-based update of the 30+-year-old content of the Baby Check App to empower parents and carers.

Objective: To systematically review clinical guidelines for signs and symptoms related to serious illness in infants aged 6 months and below.

View Article and Find Full Text PDF

A 45-year-old man presented with a diffuse petechial rash and a non-blanching palpable purpura, mainly on his lower extremities, some of which had coalesced, blistered, and ulcerated. The patient had a history of hypercoagulability and was chronically on anticoagulant medication. The rash appeared a week after starting apixaban 5 mg twice daily by mouth.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!